Sleep Apnea Devices Market Poised for Steady Growth, Fueled by Innovation and Rising Surgical Volumes | DelveInsight

The global sleep apnea devices market, valued at USD 7.53 billion in 2023, is projected to grow at a CAGR of 6.26% from 2024 to 2030, reaching USD 10.82 billion by 2030. Growth is driven by the rising prevalence of sleep apnea, increasing obesity rates, and greater adoption of advanced technologies. Additional factors such as heightened awareness, a growing elderly population, and a surge in product launches and approvals are further fueling market expansion during 2022-2030.

DelveInsight's Sleep Apnea Devices Market Insights report provides the current and forecast market analysis, individual leading Sleep Apnea Devices companies' market shares, challenges, Sleep Apnea Devices market drivers, barriers, and trends, and key Sleep Apnea Devices companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Sleep Apnea Devices Market Report
The Sleep Apnea Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Sleep Apnea Devices market during the forecast period.
Notable Sleep Apnea Devices companies such as Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and several others are currently operating in the Sleep Apnea Devices market.
On September 18, 2024, Vivos Therapeutics, Inc. announced receiving FDA 510(k) clearance for its oral medical device designed to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. This achievement underscores the company's dedication to enhancing pediatric sleep health and strengthens its leadership position in the field.
In October 2022, Airway Management introduced flexTAP, a premium custom-made oral appliance designed to address snoring and mild to moderate obstructive sleep apnea.
In August 2021, Vivos Therapeutics, Inc. obtained FDA approval for its intraoral devices targeting snoring and obstructive sleep apnea.
In March 2020, the FDA cleared eXciteOSA by Signifier Medical Technologies, a neuromuscular tongue stimulator aimed at reducing snoring and obstructive sleep apnea.
To read more about the latest highlights related to the Sleep Apnea Devices market, get a snapshot of the key highlights entailed in the Global Sleep Apnea Devices Market Report https://www.delveinsight.com/sample-request/sleep-apnea-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Sleep Apnea Devices Overview

Sleep apnea devices are designed to diagnose and manage sleep apnea-a disorder characterized by repeated interruptions in breathing during sleep, often leading to poor sleep quality, daytime fatigue, and long-term health risks such as cardiovascular issues.

Sleep Apnea Devices Market Insights

North America is projected to hold the largest share of the sleep apnea devices market in 2023, driven by factors such as the rising prevalence of sleep apnea and insomnia, a growing elderly population, and an increase in chronic nasal congestion cases. Additional contributors include high disposable income, advanced healthcare infrastructure, strong regulatory approvals, and widespread awareness of sleep apnea treatments.

According to the CDC (2022), in 2020, 14.5% of U.S. adults reported difficulty falling asleep most days, with higher rates among older adults and certain demographic groups. Sleep problems can lead to insomnia, depression, anxiety, daytime fatigue, and breathing disorders like obstructive sleep apnea (OSA), often linked to snoring caused by reduced pharyngeal muscle tone during sleep. The need to manage such conditions is expected to further boost demand for sleep apnea devices in the region.

To know more about why North America is leading the market growth in the Sleep Apnea Devices market, get a snapshot of the Sleep Apnea Devices Market Outlook https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Sleep Apnea Devices Market Dynamics

The sleep apnea devices market is growing steadily, fueled by the rising prevalence of conditions like diabetes, asthma, and sinusitis. Diabetes, in particular, can impair respiratory control and airway reflexes, increasing the risk of sleep disturbances and the need for supportive devices. According to the IDF Diabetes Atlas 2021, diabetes affects over 537 million adults globally, projected to reach 643 million by 2030, which may further drive demand for sleep apnea devices.

In the US, market growth is supported by a high burden of sleep disorders, advanced diagnostics, increasing awareness, and a robust presence of global and domestic players offering CPAP machines, oral appliances, and wearables. Investments in telehealth, homecare solutions, and R&D to improve patient comfort and compliance are set to further boost the sector.

Sleep Apnea Devices Market Drivers:
Increasing prevalence of sleep apnea
Rising geriatric population base across the globe

Get a sneak peek at the Sleep Apnea Devices market dynamics @ https://www.delveinsight.com/sample-request/sleep-apnea-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Sleep Apnea Devices Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Sleep Apnea Devices Companies: Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Which MedTech key players in the Sleep Apnea Devices market are set to emerge as the trendsetter, explore @ Sleep Apnea Devices Companies https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.